Tryton Medical, Inc., the leading developer of stents designed to treat bifurcation lesions, announced that it has received CE Mark for the treatment of Left Main Coronary artery disease.
from Content Keyword RSS http://ift.tt/1brcCt1
via IFTTT
from Content Keyword RSS http://ift.tt/1brcCt1
via IFTTT
No comments:
Post a Comment